The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy - Part 4
In the final episode of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss the abstract she presented at the AAN Annual Meeting and details on the upcoming gene therapy trial…
Read the full articleYou might also wanna read
Life Biosciences Conducts First Gene Therapy Trial to Reverse Cellular Aging in Patient with Glaucoma
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The ris
popularmechanics.com·20d agoJohnson & Johnson Discontinues JNJ-1887 Gene Therapy Program for Geographic Atrophy
July 16, 2026 — Johnson & Johnson has discontinued development of JNJ-1887, its investigational AAV2-based gene therapy for geographic atrop
One-Time Gene Therapy Restores Vision in 6-Year-Old with Rare Congenital Blindness
Saffie Sandford from Stevenage was diagnosed with Leber's Congenital Amaurosis, (LCA) a mutation in the RPE 65 gene.
goodnewsnetwork.org·26d ago
Vision researcher explains her work on retinal regeneration and gene therapy
Interview with Abigail Hackam, PhD, a professor of ophthalmology at the University of Miami's Bascom Palmer Eye Institute
FDA Approves First Dual-AAV Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program
The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) ve
FDA·2mo ago
Can a world-first gene therapy reverse ageing? – podcast
The first person has been treated with a highly anticipated new gene therapy that aims to turn back the clock on ageing cells. The trial is
Comments
Sign in to join the conversation.
No comments yet. Be the first.